Developer docs
API playgroundTry for free, no card

Search company profiles

Orgentec Diagnostika

Full company profile

uuid000bz86

Namestring
Orgentec Diagnostika
Legal namestring
ORGENTEC Diagnostika GmbH
Websiteurl
orgentec.com
Company typeenum
Private
Founded yearint
1988
Descriptiontext

Orgentec Diagnostika GmbH is a Mainz, Germany-headquartered in-vitro diagnostics (IVD) company founded in 1988 that develops, manufactures, and markets test systems for laboratory diagnostics, with particular depth in autoimmune and infectious disease testing. Its core product platform is the Alegria® family of random-access ELISA analyzers, including the next-generation Alegria® 2, which runs proprietary SMC® (Sensotronic Memorized Calibration) Monotest strips containing complete reagent sets with barcode-encoded lot-specific calibration, cut-off controls, and expiration data. The company complements the automated Alegria platform with over 200 manual ELISA kits, immunofluorescence (IFT/IFA) assays using HEp-2 cells and tissue substrates, and branded specialty tests including Anti-MCV® and Anti-CCP hs® for rheumatoid arthritis, Anti-dsDNA for SLE, fecal calprotectin for IBD/IBS differentiation, and 25-OH Vitamin D3/D2. The full portfolio exceeds 300 laboratory tests across rheumatology, thrombosis, vasculitis, gastroenterology, thyroid, diabetes, and infectious serology.

The business model is B2B sale of IVD reagents, kits, and analyzers to medical laboratories in more than 100 countries. Distribution is hybrid: direct sales via own employees or branches in Germany, Austria, Hungary, France, and Switzerland, with an established distributor network in other international markets. Post the September 2021 acquisition by Sebia Group — a French IVD leader in protein electrophoresis — Orgentec operates as a wholly-owned subsidiary and Sebia legal entity aligned with the parent brand as of 2024, while remaining the legal manufacturer of its products from Mainz. Quality management is certified to ISO 13485, all IVD products carry CE marking, and the company participates in external proficiency programs (INSTAND, UK NEQUAS, RCPA, ÖQUASTA). Customer base is fragmented across clinical and medical diagnostic laboratories, served in part via the myAlegria technician/distributor portal and supported by literature services and conference presence at events such as the International Congress on Autoimmunity.

Short descriptiontext

Orgentec Diagnostika is a Mainz, Germany-based in-vitro diagnostics company developing automated ELISA analyzers (Alegria®) and over 300 autoimmune and infectious disease tests, serving medical laboratories in 100+ countries as a wholly-owned subsidiary of Sebia Group since 2021.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMainz, Germany
HQ citystring
Mainz
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
autoimmune diagnostics, infectious disease testing, ELISA test systems, immunofluorescence assays, automated immunoassay analyzers
Industry3 codes
1Autoimmune, Allergy & Specialized Immunology Diagnostics
CodeHLAHAAAKPrimaryYes
2Immunoassay Diagnostics (ELISA, chemiluminescence, serology)
CodeHLAAALABPrimaryNo
3Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels)
CodeHLAAALACPrimaryNo
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Surgical & Medical Instruments & Apparatus3841
Product category
Clinical Diagnostics Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1In-vitro Diagnostic Products
TypeOne Time License
Description

Sale of diagnostic test systems including ELISA test kits, immunofluorescence tests, automated analyzers (Alegria®), and reagents. Products are sold directly to medical laboratories and through distribution partners.

orgentec.com
2Quality Control Reagents
TypeOne Time License
Description

Sale of control reagents for monitoring Alegria® system performance, including multi-parameter specific serum controls for daily internal quality control in autoimmune laboratories.

orgentec.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Alegria®
Description

Fully automated laboratory diagnostic system using monotest technology for autoimmune diagnostics and infectious serology.

orgentec.com
+2 more records
Core offering1 text field

Orgentec Diagnostika develops, manufactures, and markets in-vitro diagnostic test systems and reagents for clinical laboratories. Its portfolio centers on autoimmune and infectious disease diagnostics, delivered through ELISA microplate tests, immunofluorescence assays, and the fully automated Alegria® random-access analyzer platform based on its proprietary SMC® technology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • More than 60 million Alegria® tests performed in over 80 countries
+4 more records
Product overview1 text field

Orgentec Diagnostika offers a comprehensive portfolio of in vitro diagnostic products for autoimmune and infectious disease testing. The core platform is the Alegria® automated laboratory system, available in two generations (Alegria® and Alegria® 2), which uses proprietary SMC® Technology with Monotest strips for flexible, random-access testing. Supporting this platform are over 200 manual ELISA test systems and immunofluorescence (IFT/IFA) assays covering rheumatology, thrombosis, vasculitis, gastroenterology, thyroid, and diabetes diagnostics. The company also provides stool diagnostics (calprotectin), bone metabolism tests (Vitamin D), infectious disease serology panels, and autoimmune quality controls. All products are manufactured at the Mainz facility and distributed to laboratories in over 100 countries.

Product and service7 records
1Alegria® Random-Access Analyzer
CategoryAutomated Immunoassay Instruments
Description

Fully automated, random-access bench-top immunoassay analyzer that processes SMC®-based single-test strips for autoimmune and infectious serology. Designed for mid-volume clinical and hospital laboratories seeking walk-away automation.

2Alegria® 2 Analyzer
CategoryAutomated Immunoassay Instruments
Description

Next-generation version of the Alegria® analyzer offering higher throughput and connectivity features for routine autoimmune and infectious disease testing in clinical laboratories.

3ELISA Test Systems
CategoryDiagnostic Reagents
Description

Microplate-based enzyme-linked immunosorbent assay kits used by clinical laboratories for the qualitative and quantitative detection of autoantibodies and infectious-disease markers in patient samples.

4Immunofluorescence Assays (IFA)
CategoryDiagnostic Reagents
Description

Substrate slides and配套 reagents for indirect immunofluorescence detection of autoantibodies, used by specialized immunology laboratories for confirmatory testing.

5Autoimmune Diagnostic Reagents
CategoryDiagnostic Reagents
Description

Broad menu of test kits covering autoimmune markers such as ANA, ANCA, ENA, dsDNA, and other disease-specific autoantibodies, available across ELISA, IFA, and Alegria® SMC® strip formats.

6Infectious Disease Diagnostic Reagents
CategoryDiagnostic Reagents
Description

Serology kits for infectious disease markers including borreliosis (Lyme disease), EBV, Helicobacter pylori, and other pathogens, offered in ELISA and Alegria® SMC® formats for clinical labs.

7OrgSys Software
CategoryLaboratory Middleware Software
Description

Laboratory middleware software for controlling Alegria® analyzers, managing test orders, processing results, and supporting laboratory information system workflows.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

EUROIMMUN, now part of Revvity/PerkinElmer, is one of the world's leading manufacturers of autoimmune diagnostics with a broad ELISA, immunofluorescence, and blot test portfolio. It is the most direct comparable to ORGENTEC in autoimmune IVD product mix and target customer (medical laboratories).

TypeOthers
Description

Tecan is a leading manufacturer of laboratory automation instruments and OEM platforms for IVD companies. It is comparable to ORGENTEC as a provider of automated analyzer hardware used in clinical labs, though Tecan operates as an enabler and instrument supplier rather than a direct autoimmune diagnostics competitor.

TypeDirect peer
Description

Trinity Biotech offers a portfolio of autoimmune and infectious disease diagnostic tests, with ELISA and immunofluorescence products. It serves clinical laboratories globally and overlaps with ORGENTEC in autoimmune serology and infectious disease diagnostics.

TypeBroad incumbent
Description

Roche Diagnostics is the world's largest IVD manufacturer with cobas and Elecsys immunoassay platforms covering a comprehensive autoimmune and infectious serology menu. It competes with ORGENTEC for hospital laboratory budgets but as a broad-line incumbent offering full laboratory automation.

TypeDirect peer
Description

Inova Diagnostics, owned by Werfen, specializes in autoimmune disease diagnostics including ELISA, immunofluorescence, and multiplex assays. It directly competes with ORGENTEC in rheumatology, vasculitis, and connective tissue disease serology panels served to clinical laboratories.

TypeDirect peer
Description

AESKU Diagnostics develops and markets autoimmune diagnostic test systems including ELISA and immunofluorescence products. It is a niche-focused direct peer to ORGENTEC with comparable target customers (clinical laboratories) and overlapping autoimmune test menus.

TypeDirect peer
Description

ZEUS Scientific manufactures ELISA and immunofluorescence test systems focused on autoimmune and infectious disease diagnostics. It is a direct peer to ORGENTEC in product format (manual ELISA kits, IFA substrates) and customer base (specialty clinical labs).

TypeBroad incumbent
Description

Thermo Fisher Scientific, through its Phadia / ImmunoCAP allergy and autoimmune franchise, is a major broad-line IVD player in autoimmune diagnostics. It overlaps with ORGENTEC in autoimmune testing but serves a much larger customer base via fully automated high-throughput platforms.

TypeBroad incumbent
Description

Abbott Diagnostics operates a broad IVD portfolio including Architect and Alinity immunoassay systems that include autoimmune and specialty serology panels. It competes with ORGENTEC in clinical laboratories but as a diversified diagnostics incumbent rather than an autoimmune specialist.

TypeBroad incumbent
Description

Bio-Rad Laboratories is a broad life science and clinical diagnostics company with a meaningful autoimmune and infectious disease testing portfolio, including the BioPlex 2200 multiplex system. It competes with ORGENTEC in specialty autoimmune serology but as part of a much wider IVD and research product portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Orgentec Diagnostika

Clinical Diagnostics Reagentsorgentec.com

Orgentec Diagnostika is a Mainz, Germany-based in-vitro diagnostics company developing automated ELISA analyzers (Alegria®) and over 300 autoimmune and infectious disease tests, serving medical laboratories in 100+ countries as a wholly-owned subsidiary of Sebia Group since 2021.

What Orgentec Diagnostika does

Orgentec Diagnostika GmbH is a Mainz, Germany-headquartered in-vitro diagnostics (IVD) company founded in 1988 that develops, manufactures, and markets test systems for laboratory diagnostics, with particular depth in autoimmune and infectious disease testing. Its core product platform is the Alegria® family of random-access ELISA analyzers, including the next-generation Alegria® 2, which runs proprietary SMC® (Sensotronic Memorized Calibration) Monotest strips containing complete reagent sets with barcode-encoded lot-specific calibration, cut-off controls, and expiration data. The company complements the automated Alegria platform with over 200 manual ELISA kits, immunofluorescence (IFT/IFA) assays using HEp-2 cells and tissue substrates, and branded specialty tests including Anti-MCV® and Anti-CCP hs® for rheumatoid arthritis, Anti-dsDNA for SLE, fecal calprotectin for IBD/IBS differentiation, and 25-OH Vitamin D3/D2. The full portfolio exceeds 300 laboratory tests across rheumatology, thrombosis, vasculitis, gastroenterology, thyroid, diabetes, and infectious serology.

The business model is B2B sale of IVD reagents, kits, and analyzers to medical laboratories in more than 100 countries. Distribution is hybrid: direct sales via own employees or branches in Germany, Austria, Hungary, France, and Switzerland, with an established distributor network in other international markets. Post the September 2021 acquisition by Sebia Group — a French IVD leader in protein electrophoresis — Orgentec operates as a wholly-owned subsidiary and Sebia legal entity aligned with the parent brand as of 2024, while remaining the legal manufacturer of its products from Mainz. Quality management is certified to ISO 13485, all IVD products carry CE marking, and the company participates in external proficiency programs (INSTAND, UK NEQUAS, RCPA, ÖQUASTA). Customer base is fragmented across clinical and medical diagnostic laboratories, served in part via the myAlegria technician/distributor portal and supported by literature services and conference presence at events such as the International Congress on Autoimmunity.

Orgentec Diagnostika firmographics

Firmographics
Name
Orgentec Diagnostika
Legal name
ORGENTEC Diagnostika GmbH
Website
https://orgentec.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
11–50 employees
Short description
Orgentec Diagnostika is a Mainz, Germany-based in-vitro diagnostics company developing automated ELISA analyzers (Alegria®) and over 300 autoimmune and infectious disease tests, serving medical laboratories in 100+ countries as a wholly-owned subsidiary of Sebia Group since 2021.
Ownership category
akta.pro rank

Orgentec Diagnostika industry classification

Industry
Product category
Clinical Diagnostics Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)
akta.pro secondary industries
Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

  • Autoimmune diagnostics
  • Infectious disease testing
  • ELISA test systems
  • Immunofluorescence assays
  • Automated immunoassay analyzers

Where Orgentec Diagnostika is headquartered

Location

Headquarters

HQ city
Mainz
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Orgentec Diagnostika business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. In-vitro Diagnostic Products: Sale of diagnostic test systems including ELISA test kits, immunofluorescence tests, automated analyzers (Alegria®), and reagents. Products are sold directly to medical laboratories and through distribution partners.
  2. Quality Control Reagents: Sale of control reagents for monitoring Alegria® system performance, including multi-parameter specific serum controls for daily internal quality control in autoimmune laboratories.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Orgentec Diagnostika product offering

Product offering

Core offering

Orgentec Diagnostika develops, manufactures, and markets in-vitro diagnostic test systems and reagents for clinical laboratories. Its portfolio centers on autoimmune and infectious disease diagnostics, delivered through ELISA microplate tests, immunofluorescence assays, and the fully automated Alegria® random-access analyzer platform based on its proprietary SMC® technology.

Product overview

Orgentec Diagnostika offers a comprehensive portfolio of in vitro diagnostic products for autoimmune and infectious disease testing. The core platform is the Alegria® automated laboratory system, available in two generations (Alegria® and Alegria® 2), which uses proprietary SMC® Technology with Monotest strips for flexible, random-access testing. Supporting this platform are over 200 manual ELISA test systems and immunofluorescence (IFT/IFA) assays covering rheumatology, thrombosis, vasculitis, gastroenterology, thyroid, and diabetes diagnostics. The company also provides stool diagnostics (calprotectin), bone metabolism tests (Vitamin D), infectious disease serology panels, and autoimmune quality controls. All products are manufactured at the Mainz facility and distributed to laboratories in over 100 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Alegria®: Fully automated laboratory diagnostic system using monotest technology for autoimmune diagnostics and infectious serology.
  • Alegria® 2
  • SMC® Technology (Sensotronic Memorized Calibration)

Products and services

  • Alegria® Random-Access Analyzer Fully automated, random-access bench-top immunoassay analyzer that processes SMC®-based single-test strips for autoimmune and infectious serology. Designed for mid-volume clinical and hospital laboratories seeking walk-away automation.
  • Alegria® 2 Analyzer Next-generation version of the Alegria® analyzer offering higher throughput and connectivity features for routine autoimmune and infectious disease testing in clinical laboratories.
  • ELISA Test Systems Microplate-based enzyme-linked immunosorbent assay kits used by clinical laboratories for the qualitative and quantitative detection of autoantibodies and infectious-disease markers in patient samples.
  • Immunofluorescence Assays (IFA) Substrate slides and配套 reagents for indirect immunofluorescence detection of autoantibodies, used by specialized immunology laboratories for confirmatory testing.
  • Autoimmune Diagnostic Reagents Broad menu of test kits covering autoimmune markers such as ANA, ANCA, ENA, dsDNA, and other disease-specific autoantibodies, available across ELISA, IFA, and Alegria® SMC® strip formats.
  • Infectious Disease Diagnostic Reagents Serology kits for infectious disease markers including borreliosis (Lyme disease), EBV, Helicobacter pylori, and other pathogens, offered in ELISA and Alegria® SMC® formats for clinical labs.
  • OrgSys Software Laboratory middleware software for controlling Alegria® analyzers, managing test orders, processing results, and supporting laboratory information system workflows.

Quantifiable outcome

  • More than 60 million Alegria® tests performed in over 80 countries
  • +4 more outcomes

Companies that use Orgentec Diagnostika

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Orgentec Diagnostika technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Orgentec Diagnostika partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Orgentec Diagnostika competitors and assessment

Company assessment

Direct peers

  • EUROIMMUN (PerkinElmer): EUROIMMUN, now part of Revvity/PerkinElmer, is one of the world's leading manufacturers of autoimmune diagnostics with a broad ELISA, immunofluorescence, and blot test portfolio. It is the most direct comparable to ORGENTEC in autoimmune IVD product mix and target customer (medical laboratories).
  • Trinity Biotech: Trinity Biotech offers a portfolio of autoimmune and infectious disease diagnostic tests, with ELISA and immunofluorescence products. It serves clinical laboratories globally and overlaps with ORGENTEC in autoimmune serology and infectious disease diagnostics.
  • Inova Diagnostics (Werfen): Inova Diagnostics, owned by Werfen, specializes in autoimmune disease diagnostics including ELISA, immunofluorescence, and multiplex assays. It directly competes with ORGENTEC in rheumatology, vasculitis, and connective tissue disease serology panels served to clinical laboratories.
  • AESKU Diagnostics: AESKU Diagnostics develops and markets autoimmune diagnostic test systems including ELISA and immunofluorescence products. It is a niche-focused direct peer to ORGENTEC with comparable target customers (clinical laboratories) and overlapping autoimmune test menus.
  • ZEUS Scientific: ZEUS Scientific manufactures ELISA and immunofluorescence test systems focused on autoimmune and infectious disease diagnostics. It is a direct peer to ORGENTEC in product format (manual ELISA kits, IFA substrates) and customer base (specialty clinical labs).

Others

  • Tecan: Tecan is a leading manufacturer of laboratory automation instruments and OEM platforms for IVD companies. It is comparable to ORGENTEC as a provider of automated analyzer hardware used in clinical labs, though Tecan operates as an enabler and instrument supplier rather than a direct autoimmune diagnostics competitor.

Broad incumbents

  • Roche Diagnostics: Roche Diagnostics is the world's largest IVD manufacturer with cobas and Elecsys immunoassay platforms covering a comprehensive autoimmune and infectious serology menu. It competes with ORGENTEC for hospital laboratory budgets but as a broad-line incumbent offering full laboratory automation.
  • Thermo Fisher Scientific (Phadia): Thermo Fisher Scientific, through its Phadia / ImmunoCAP allergy and autoimmune franchise, is a major broad-line IVD player in autoimmune diagnostics. It overlaps with ORGENTEC in autoimmune testing but serves a much larger customer base via fully automated high-throughput platforms.
  • Abbott Diagnostics: Abbott Diagnostics operates a broad IVD portfolio including Architect and Alinity immunoassay systems that include autoimmune and specialty serology panels. It competes with ORGENTEC in clinical laboratories but as a diversified diagnostics incumbent rather than an autoimmune specialist.
  • Bio-Rad Laboratories: Bio-Rad Laboratories is a broad life science and clinical diagnostics company with a meaningful autoimmune and infectious disease testing portfolio, including the BioPlex 2200 multiplex system. It competes with ORGENTEC in specialty autoimmune serology but as part of a much wider IVD and research product portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Orgentec Diagnostika social profiles

Digital presence

Orgentec Diagnostika compliance and trust

Trust signal

Compliance2 records

Orgentec Diagnostika financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Orgentec Diagnostika leadership team

Management profile

Number of profiles

Profiles3 records

Orgentec Diagnostika funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Orgentec Diagnostika M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orgentec Diagnostika

What does Orgentec Diagnostika do?

Orgentec Diagnostika develops, manufactures, and markets in-vitro diagnostic test systems and reagents for clinical laboratories. Its portfolio centers on autoimmune and infectious disease diagnostics, delivered through ELISA microplate tests, immunofluorescence assays, and the fully automated Alegria® random-access analyzer platform based on its proprietary SMC® technology.

Is Orgentec Diagnostika a public or private company?

Orgentec Diagnostika is a private company. It is classified as corporate owned and is currently operating.

When was Orgentec Diagnostika founded?

Orgentec Diagnostika was founded in 1988. It employs 11 to 50 people.

Where is Orgentec Diagnostika based?

Orgentec Diagnostika is headquartered in Mainz, Germany, in the Europe region.

How does Orgentec Diagnostika make money?

Two revenue lines are on record. In-vitro Diagnostic Products are the primary driver. The others are quality Control Reagents.

Who are Orgentec Diagnostika's main competitors?

Direct peers on record are EUROIMMUN (PerkinElmer), Trinity Biotech, Inova Diagnostics (Werfen), AESKU Diagnostics and ZEUS Scientific. Tecan is listed as an others. Broad incumbents are Roche Diagnostics, Thermo Fisher Scientific (Phadia), Abbott Diagnostics and Bio-Rad Laboratories.

Does Orgentec Diagnostika have an API?

No public API is recorded for Orgentec Diagnostika.

What industry is Orgentec Diagnostika in?

Orgentec Diagnostika's product category is Clinical Diagnostics Reagents. Its primary akta.pro industry code is HLAHAAAK, Autoimmune, Allergy & Specialized Immunology Diagnostics, with a secondary code of HLAAALAB, Immunoassay Diagnostics (ELISA, chemiluminescence, serology). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireWater Street conclut la vente d'Orgentec DiagnostikaWater Street Healthcare Partners has completed the sale of its portfolio company Orgentec Diagnostika to Sebia, a global provider of in-vitro diagnostic technologies. This transaction marks the conclusion of Water Street's seven-year investment period, during which it expanded Orgentec's global presence and product portfolio through strategic acquisitions and R&D investments.PR NewswireWater Street schließt den Verkauf von Orgentec Diagnostika abWater Street Healthcare Partners completed the sale of specialty diagnostics company Orgentec Diagnostika to Sebia, a global in-vitro diagnostics technology provider headquartered in Lisses, France. Water Street had invested in Orgentec in 2014 and, over seven years, expanded the company into a leading provider of specialty diagnostics for autoimmune and infectious diseases, facilitating acquisitions and growing its reach to customers in over 100 countries. The transaction marks a successful exit for Water Street, which built Orgentec into a company with a portfolio of more than 300 tests.PR NewswireWater Street rondt verkoop van Orgentec Diagnostika afWater Street Healthcare Partners has completed the sale of Orgentec Diagnostika, a specialized diagnostics company, to Sebia, a leading in-vitro diagnostic technology provider headquartered in Lisses, France. Over the seven years since Water Street's 2014 investment, Orgentec grew into a leading global supplier of specialized diagnostic solutions for autoimmune and infectious diseases, expanding to customers in more than 100 countries and growing its portfolio to over 300 tests. The transaction represents the culmination of Water Street's strategic effort to build Orgentec into a major player in specialized diagnostics under the leadership of CEO Gary Winer.PR NewswireWater Street Completes Sale of Orgentec DiagnostikaWater Street Healthcare Partners has completed the sale of specialty diagnostics company Orgentec Diagnostika to Sebia, a France-based world-leading provider of in-vitro diagnostic testing technology. Water Street invested in Orgentec in 2014 and transformed it into a leading specialty diagnostic provider offering 300+ tests across more than 100 countries through acquisitions including Arotec Diagnostics and Corgenix Medical. The transaction represents a successful exit for Water Street and strengthens Sebia's position in the global specialty diagnostics market.Les EchosSebia met la main sur l’allemand Orgentec DiagnostikaSebia has acquired the German company Orgentec Diagnostika from the private equity firm Water Street Healthcare Partners. Orgentec, based in Mainz and specializing in serological tests for autoimmune and infectious diseases, reported a revenue of 50 million euros. This acquisition follows Sebia's previous expansion into Italy with Interlab and aims to strengthen Sebia's product offering.PR NewswireSebia acquiert Orgentec DiagnostikaSebia announced the acquisition of ORGENTEC Diagnostika from investor Water Street Healthcare Partners to expand its capabilities in autoimmunity, infectious diseases, and clinical testing. The transaction, expected to close within the next quarter, integrates ORGENTEC's subsidiaries Corgenix Medical Corporation and AROTEC Diagnostics Limited into Sebia's global portfolio.PR NewswireSebia neemt Orgentec Diagnostika overSebia, a French global leader in clinical protein electrophoresis equipment, has acquired ORGENTEC Diagnostika, a German specialist diagnostics company owned by Water Street Healthcare Partners, for an undisclosed amount, with closing expected in the next quarter. The acquisition will expand Sebia's capabilities in autoimmunity, infectious diseases, and clinical trials while adding ORGENTEC's portfolio of autoimmune and blood diagnostics to its global operations.PR NewswireSebia erwirbt Orgentec DiagnostikaSebia, a French leader in clinical protein electrophoresis, has agreed to acquire Orgentec Diagnostika, a global specialist in autoimmune disease diagnostics, from Water Street Healthcare Partners for an undisclosed amount, with closing expected next quarter. Orgentec, headquartered in Mainz, Germany, operates two fully integrated business units — Corgenix in Colorado and AROTEC Diagnostics in New Zealand — and brings market-leading autoimmune testing menus and the Alegria serology platform to Sebia's portfolio. The acquisition is intended to expand Sebia's capabilities in autoimmunity, infectious diseases, and clinical trials while accelerating innovation and global commercial network growth.PR NewswireSebia Acquires Orgentec DiagnostikaSebia announced the acquisition of specialty diagnostic leader ORGENTEC Diagnostika from Water Street Healthcare Partners, with the transaction expected to close in the next quarter. This strategic move expands Sebia's capabilities in autoimmunity, infectious diseases, and clinical trials by integrating ORGENTEC’s market-leading testing menus and instruments. The acquisition also brings Corgenix Medical Corporation and AROTEC Diagnostics Limited into Sebia’s portfolio, enhancing its global commercial network and R&D programs.BioSpaceSebia Acquires Orgentec DiagnostikaSebia has announced the acquisition of specialty diagnostic leader ORGENTEC Diagnostika from strategic investor Water Street Healthcare Partners for an undisclosed amount. The transaction, expected to close in the next quarter, aims to expand Sebia's capabilities in autoimmunity, infectious diseases, and clinical trials by integrating ORGENTEC's market-leading testing menu and instruments.